All stock lists
Ares Management Corp (New York Stock Exchange:ARES)
US · Delayed Price · Currency is USD
Financial Services · Asset Management
121.70-0.38 (-0.31%)
Insider Score
––Not scored
ARES Insider Score
Insiders here have filed 7 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ARES analyst forecast
ARES analyst consensus
Moderate Buy7 ratings
Buy 5 Hold 2 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
ARES 12-month price target
$162.00+33.1% upsideaverage of 7 firms
$201.00High
$134.00Low
Best analysts covering ARES
- Piper Sandler100%success rate · 2 calls
- JP Morgan75%success rate · 4 calls
- Barclays73%success rate · 22 calls
- RBC Capital69%success rate · 13 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ARES analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-10-19 |
| — | UBS | Neutral | — | — | Reiterated | 2026-10-13 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-10-12 |
| Wells Fargo | — | $136.00 | +16.7% | — | 2026-10-01 | |
| Piper Sandler | — | $150.00 | +23.5% | — | 2026-09-24 | |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-08-27 |
| BMO Capital | Market Perform | $134.00 | +4.6% | Reiterated | 2026-08-03 | |
| RBC Capital | Outperform | $168.00 | +25.0% | Reiterated | 2026-08-03 | |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-08-03 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-08-03 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-08-03 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-07-17 |
| — | BMO Capital | Market Perform | — | — | Reiterated | 2026-07-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-07-09 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-07-09 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-06-23 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-05-18 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-05-04 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-05-04 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-04-28 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-04-22 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-04-21 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-04-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-04-08 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-04-07 |
| — | BMO Capital | Market Perform | — | — | Reiterated | 2026-03-24 |
| RBC Capital | Outperform | $173.00 | +49.2% | Reiterated | 2026-02-24 | |
| — | Raymond James | Strong Buy | — | — | Upgraded | 2026-02-09 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-02-09 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-02-09 |
| Deutsche Bank | Buy | $155.00 | +27.2% | Upgraded | 2026-02-09 | |
| — | Barclays | Overweight | — | — | Reiterated | 2026-02-06 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-02-06 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-01-14 |
| — | UBS | Neutral | — | — | Reiterated | 2026-01-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-01-09 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-12-12 |
| UBS | — | $201.00 | +12.7% | — | 2025-12-11 | |
| — | TD Cowen | Buy | — | — | Reiterated | 2025-11-04 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2025-11-04 |
| Oppenheimer | — | $190.00 | +23.6% | — | 2025-11-04 | |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-10-21 |
| — | Oppenheimer | Outperform | — | — | Upgraded | 2025-10-14 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-10-08 |
| — | B of A Securities | Buy | — | — | Reiterated | 2025-10-03 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-09-29 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-08-18 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-08-06 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2025-08-04 |
| JMP Securities | Market Outperform | $195.00 | +8.1% | Reiterated | 2025-07-14 | |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-07-11 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-07-10 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-05-23 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-05-08 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-05-06 |
| Barclays | Overweight | $182.00 | +13.1% | Reiterated | 2025-05-06 | |
| Wolfe Research | — | $193.00 | +20.9% | — | 2025-05-06 | |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-04-14 |
ARES earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-05 | 1.69 | 1.45 | $1.49B | $1.50B |
| 2026-05-01 | 1.33 | 1.24 | $1.28B | $1.29B |
| 2026-07-31 | 1.28 | 1.29 | $1.27B | $1.43B |
| 2026-10-29 | 1.25 | 0.00 | $1.24B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.